Industry
BioMosaics Obtains Rights to Liver Cancer Test
A novel diagnostic test for hepatocellular carcinoma (HCC) has been licensed to BioMosaics, Inc. which employs a unique monoclonal antibody to glypican 3 (GPC3), known to have increased expression in HCC and shown to be detectable in tissue specimens and serum. More...30 Nov -0001
New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Benchtop Thermomixer
Biometra TS1 ThermoShaker
New
Immunofluorescence Analyzer
IFA System
In Other News
R&D Systems to Develop Cytokine Assays for Beckman
Inverness Buys Rapid Tests from Abbott for $92.5 Million
Bacterial BarCodes and Agilent in Marketing Agreement
International Remote Imaging Plans Name Change
DakoCytomation Acquires Gastric Ulcer Test
Inverness to Acquire Applied Biotech from Apogent
Roche to Acquire Igen for $1.26 Billion
Collaboration to Promote Test Identifying Heparin Risk
CalbaTech Seeks Majority Stake in Qicc
Lab Corp and Atherotech Form Marketing Alliance
Group to Develop Alcohol-Sensor Device
Abbott and Promega to Develop Molecular Diagnostics Products
Infection-Control Award Offered by Oxoid
Abbott and Artus in Alliance for SARS Test
New In Vitro Diagnostics Company Formed
Molecular Probes Acquires Interfacial Dynamics
Molecular Probes Licenses Fluorescence Technology to LightUp
Lab-on-a-Chip Market to Reach $709 Million by 2008
Quest to Offer Cancer Screening Products of TriPath Imaging
SpectRx Gets Grant for Cervical Cancer Detection Device
LabCorp to Acquire Certain Assets of Quest Diagnostics
European Market for Hematology Diagnostics
Dade Behring Acquires Rights to Cardiac Marker
LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
